86
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Dihydroartemisinin–piperaquine versus artemether–lumefantrine, in the treatment of uncomplicated Plasmodiumfalciparum malaria in central Sudan

, , , , &
Pages 319-326 | Published online: 18 Jul 2013

References

  • Adam, I., Ibrahim, M. H., A/Elbasit, I. & Elbashir, M. I. (2004a). Efficacy of sulphadoxine—pyrimetha-mine in the treatment of uncomplicated Plasmodium falciparum malaria in a small sample of Sudanese children. East Mediterranean Health Journal, 10, 309–314.
  • Adam, I., Osman, M. E., Elghazali, G., Ahmed, G. I., Gustafson, L. L. & Elbashir, M. I., (2004b). Efficacies of chloroquine, sulphadoxine—pyrimetha-mine and quinine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan. Annals of Tropical Medicine and Parasitology, 98, 661–666.
  • Adam, I., A/Elbasit, I. E., Idris, S. M., Malik, E. M. & Elbashir, M. I. (2005a). A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. Annals of Tropical Medicine and Parasitology, 99, 449–455.
  • Adam, I., Salih, I. & Elbashir, M. I. (2005b). Quinine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 736–738.
  • Adjuik, M., Babiker, A., Gamer, P., Olliaro, P., Taylor, W. & White, N. (2004). Artesunate combinations for treatment of malaria: meta-analysis. Lancet, 363, 9–17.
  • Bassat, Q., Mulenga, M., Tinto, H., Piola, P., Borrmann, S., Menendezsn C., Nambozi, M., Valea, I., Nabasumba, C., Sasi, P., Bacchieri, A., Corsi, M., Ubben, D., Talisuna, A. & D'Alessandro, U. (2009). Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One, 17, e7871.
  • Ezzet, F., van Vugt, M., Nosten, F., Looareesuwan, S. & White, N. J. (2000) Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrobial Agents and Chemotherapy, 44, 697–704.
  • Giha, H. A. (2010). Artemisinin derivatives for treat-ment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope. Parasitology Research, 106, 549–552.
  • Malik, E. M., Atta, H. Y., Weis, M., Lang, A., Puta, C. & Lettenmaier, C. (2004). Sudan Roll Back Malaria Consultative Mission: essential actions to support the attainment of the Abuja Targets. Sudan RBM Country Consultative Mission Final Report. 2004. Geneva: Roll Back Malaria Partnership.
  • Nosten, F. & White, N. J. (2007). Artemisinin-based combination treatment of falciparum malaria. American Journal of Tropical Medicine and Hygiene, 7 (Suppl. 6), 181-192.
  • Plowe, C. V., Djimde, A., Bouare, M., Doumbo, O. & Wellems, T. E. (1995). Pyrimethamine and progua-nil resistance conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. American Journal of Tropical Medicine and Hygiene, 5, 565–568.
  • Price, R. N., Dorsey, G. & Nosten, F. (2009). Antimalarial therapies in children from Papua New Guinea. New England Journal of Medicine, 360, 1254.
  • Sagara, I., Rulisa, S., Mbacham, W., Adam, I., Sissoko, K., Maiga, H., Traore, O., Dara, N., Dicko, Y. T., Dicko, A., Djimde, A., Jansen, F. H. & Doumbo, O. K. (2009). Efficacy and safety of a fixed dose artesunate-sulfamethoxypyrazine-pyrimethamine com-pared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial. Malaria Journal, 8, 63.
  • Sinclair, D., Zani, B., Donegan, S., Olliaro, P. & Garner, P. (2009). Artemisinin-based Combination Therapy for Treating Uncomplicated Malaria. Cochrane Database of Systematic Reviews 2009. Art. No. CD007483. Chichester, U.K.: John Wiley & Sons.
  • Some, A. F., Sere, Y. Y., Dokomajilar, C., Zongo, I., Rouamba, N., Greenhouse, B., Ouedraogo, J. B. & Rosenthal, P. J. (2010). Selection of known Plasmodium falciparum resistance-mediating poly-morphisms by artemether-lumefantrine and amodia-quine/sulfadoxine-pyrimethamine, but not by dihydroartemisinin-piperaquine in Burkina Faso. Antimicrobial Agents and Chemotherapy, 54, 1949–1954.
  • White, N. J. (2002). The assessment of antimalarial drug efficacy. Trends in Parasitology, 18, 458–464.
  • World Health Organization (1993). A Global Strategy for Malaria Control. Geneva: WHO.
  • World Health Organization (2000). Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94 (Suppl.), S1-S90.
  • World Health Organization (2003). Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. Document WHO/HTM/RBM/2003.50. Geneva: WHO.
  • World Health Organization (2010). Guidelines for the Treatment of Malaria, 2nd Edn. Geneva: WHO.
  • Yeka, A., Dorsey, G., Kamya, M. R., Talisuna, A., Lugemwa, M., Rwakimari, J. B., Staedke, S. G., Rosenthal, P. J., Wabwire-Mangen, F. & Bukirwa, H. (2008). Artemether-lumefantrine versus dihydroar-temisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS One, 3, e2390.
  • Zwang, J., Ashley, E. A., Karema, C., D'Alessandro, U., Smithuis, F., Dorsey, G., Janssens, B., Mayxay, M., Newton, P., Singhasivanon, P., Stepniewska, K., White, N. J. & Nosten, F. (2009). Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS One, 4, e6358.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.